C142H165FN30O11 — CID 160959862
4-amino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoro-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-[[4-(hydroxymethyl)phenyl]methylamino]quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methyl-4-(methylamino)quinoline-3-carboxamide (PubChem CID 160959862) has the molecular formula C142H165FN30O11 and a molecular weight of 2487.08 g/mol. Its IUPAC name is 4-amino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoro-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-[[4-(hydroxymethyl)phenyl]methylamino]quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methyl-4-(methylamino)quinoline-3-carboxamide.
| Compound Name | 4-amino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoro-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-[[4-(hydroxymethyl)phenyl]methylamino]quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methyl-4-(methylamino)quinoline-3-carboxamide |
|---|---|
| PubChem CID | 160959862 |
| Molecular Formula | C142H165FN30O11 |
| Molecular Weight | 2487.08 g/mol |
| Exact Mass | 2485.33 |
| IUPAC Name | 4-amino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoro-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-[[4-(hydroxymethyl)phenyl]methylamino]quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)quinoline-3-carboxamide;6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methyl-4-(methylamino)quinoline-3-carboxamide |
| SMILES | CCCCn1ccc(-c2cc3c(N)c(C(=O)NC4CC4)cnc3cc2CO)n1.CCCCn1ccc(-c2cc3c(NC)c(C(=O)NC4CC4)cnc3cc2C)n1.CCCCn1ccc(-c2cc3c(NC)c(C(=O)NC4CC4)cnc3cc2CO)n1.CCCCn1ccc(-c2cc3c(NC)c(C(=O)NC4CC4)cnc3cc2F)n1.CCCCn1ccc(-c2cc3c(NCc4ccc(CO)cc4)c(C(=O)NC4CC4)cnc3cc2CO)n1.CCCCn1ccc(-c2cc3c(Nc4ccccc4)c(C(=O)NC4CC4)cnc3cc2CO)n1 |
| InChI | InChI=1S/C29H33N5O3.C27H29N5O2.C22H27N5O2.C22H27N5O.C21H24FN5O.C21H25N5O2/c1-2-3-11-34-12-10-26(33-34)23-14-24-27(13-21(23)18-36)30-16-25(29(37)32-22-8-9-22)28(24)31-15-19-4-6-20(17-35)7-5-19;1-2-3-12-32-13-11-24(31-32)21-15-22-25(14-18(21)17-33)28-16-23(27(34)30-20-9-10-20)26(22)29-19-7-5-4-6-8-19;1-3-4-8-27-9-7-19(26-27)16-11-17-20(10-14(16)13-28)24-12-18(21(17)23-2)22(29)25-15-5-6-15;1-4-5-9-27-10-8-19(26-27)16-12-17-20(11-14(16)2)24-13-18(21(17)23-3)22(28)25-15-6-7-15;1-3-4-8-27-9-7-18(26-27)14-10-15-19(11-17(14)22)24-12-16(20(15)23-2)21(28)25-13-5-6-13;1-2-3-7-26-8-6-18(25-26)15-10-16-19(9-13(15)12-27)23-11-17(20(16)22)21(28)24-14-4-5-14/h4-7,10,12-14,16,22,35-36H,2-3,8-9,11,15,17-18H2,1H3,(H,30,31)(H,32,37);4-8,11,13-16,20,33H,2-3,9-10,12,17H2,1H3,(H,28,29)(H,30,34);7,9-12,15,28H,3-6,8,13H2,1-2H3,(H,23,24)(H,25,29);8,10-13,15H,4-7,9H2,1-3H3,(H,23,24)(H,25,28);7,9-13H,3-6,8H2,1-2H3,(H,23,24)(H,25,28);6,8-11,14,27H,2-5,7,12H2,1H3,(H2,22,23)(H,24,28) |
| InChIKey | SWWJDMCLPCGTTL-UHFFFAOYSA-N |
| XLogP | 23.72 |
| TPSA | 546.18 Ų |
| H-Bond Donors | 17 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 49 |
| Heavy Atoms | 184 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2487.08 |
| LogP ≤ 5 | 23.72 |
| H-Bond Donors ≤ 5 | 17 |
| H-Bond Acceptors ≤ 10 | 35 |